Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yao, Hui ^a   Chi, Xinjin ^a   Jin, Yi ^a   Wang, Yiheng ^a,b   Huang, Pinjie ^a   Wu, Shan ^a   Xia, Zhengyuan ^c   Cai, Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CREATININE; DEXMEDETOMIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANIMAL; AUTOTRANSPLANTATION; BLOOD; CELL LINE; CONFOCAL MICROSCOPY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; LIVER TRANSPLANTATION; MALE; METABOLISM; PROCEDURES; RANDOMIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD UREA NITROGEN; CELL LINE; CREATININE; DEXMEDETOMIDINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; LIVER TRANSPLANTATION; MALE; MICROSCOPY, CONFOCAL; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, AUTOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947740605     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16849     Document Type: Article

References (58)

1. Aberg, F., Isoniemi, H. & Hockerstedt, K. Long-term results of liver transplantation. SCAND J SURG 100, 14-21 (2011).
2. Billings, F. T., Ball, S. K., Roberts, L. N. & Pretorius, M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 50, 1480-1487 (2011).
3. Nadim, M. K. et al. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl 18, 539-548 (2012).
4. Sakai, T., Matsusaki, T., Marsh, J. W., Hilmi, I. A. & Planinsic, R. M. Comparison of surgical methods in liver transplantation: retrohepatic caval resection with venovenous bypass (VVB) versus piggyback (PB) with VVB versus PB without VVB. TRANSPL INT 23, 1247-1258 (2010).
5. Martin-Llahi, M. et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. GASTROENTEROLOGY 140, 488-496 (2011).
6. Schrier, R. W., Wang, W., Poole, B. & Mitra, A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J CLIN INVEST 114, 5-14 (2004).
7. Borthwick, E. & Ferguson, A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 341, c3365 (2010).
8. Molitoris, B. A. & Sutton, T. A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. KIDNEY INT 66, 496-499 (2004).
9. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. NATURE 416, 750-756 (2002).
10. Zhang, L. et al. Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. Br J Anaesth 110 Suppl 1, i82-i91 (2013).
11. Gluba, A. et al. The role of Toll-like receptors in renal diseases. NAT REV NEPHROL 6, 224-235 (2010).
12. Arslan, F., Keogh, B., McGuirk, P. & Parker, A. E. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010, 704202 (2010).
13. Wu, H. et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J CLIN INVEST 117, 2847-2859 (2007).
14. Niu, X. Y. et al. Effects of intravenous and intrathecal dexmedetomidine in spinal anesthesia: a meta-analysis. CNS NEUROSCI THER 19, 897-904 (2013).
15. Sanders, R. D. & Maze, M. Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs 8, 25-33 (2007).
16. Kocoglu, H., Karaaslan, K., Gonca, E., Bozdogan, O. & Gulcu, N. Preconditionin effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats. Curr Ther Res Clin Exp 69, 150-158 (2008).
17. Hoffman, W. E., Kochs, E., Werner, C., Thomas, C. & Albrecht, R. F. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. ANESTHESIOLOGY 75, 328-332 (1991).
18. Kocoglu, H., Ozturk, H., Ozturk, H., Yilmaz, F. & Gulcu, N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail 31, 70-74 (2009).
19. Frumento, R. J. et al. Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J CLIN ANESTH 18, 422-426 (2006).
20. Eser, O. et al. The influence of dexmedetomidine on ischemic rat hippocampus. BRAIN RES 1218, 250-256 (2008).
21. Kurt, A. et al. An investigation about the inhibition of acute ischemia/reperfusion damage by dexmedetomidine in rat ovarian tissue. GYNECOL ENDOCRINOL 29, 222-225 (2013).
22. Can, M., Gul, S., Bektas, S., Hanci, V. & Acikgoz, S. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand 53, 1068-1072 (2009).
23. Randhawa, P. S. & Shapiro, R. Chronic renal failure after liver transplantation. AM J TRANSPLANT 5, 967-968 (2005).
24. Lima, E. Q. et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail 25, 553-560 (2003).
25. Ge, M. et al. Propofol pretreatment attenuates remote kidney injury induced by orthotopic liver autotransplantation, which is correlated with the activation of Nrf2 in rats. MOL MED REP 11, 3962-3968 (2015).
26. Hei, Z. Q. et al. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Chin Med J (Engl) 121, 1251-1256 (2008).
27. Jin, C. et al. Impact of hypoxic preconditioning on apoptosis and its possible mechanism in orthotopic liver autotransplantation in rats. Hepatobiliary Pancreat Dis Int 8, 40-45 (2009).
28. Zhao, H. F. et al. Biliary tract injury caused by different relative warm ischemia time in liver transplantation in rats. Hepatobiliary Pancreat Dis Int 8, 247-254 (2009).
29. Zhou, B. et al. Role of vascular endothelial growth factor in protection of intrahepatic cholangiocytes mediated by hypoxic preconditioning after liver transplantation in rats. Transplant Proc 42, 2457-2462 (2010).
30. O'Neill, L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans 28, 557-563 (2000).
31. Akira, S. & Takeda, K. Toll-like receptor signalling. NAT REV IMMUNOL 4, 499-511 (2004).
32. Yan, R. et al. Augmenter of liver regeneration attenuates inflammation of renal ischemia/reperfusion injury through the NF-kappa B pathway in rats. Int Urol Nephrol 47, 861-868 (2015).
33. Wang, L. et al. Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-kappaB pathway. EXP THER MED 9, 1253-1258 (2015).
34. Li, Y. W. et al. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene 542, 46-51(2014).
35. Lee, J. W. et al. Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-kappaB pathway in ischemia/reperfusion-induced acute kidney injury. Biochemical and biophysical research communications 444, 121-127 (2014).
36. Lee, H. T., Park, S. W., Kim, M. & D'Agati, V. D. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Laboratory investigation; a journal of technical methods and pathology 89, 196-208 (2009).
37. Tan, Z. et al. Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats. Ren Fail 37, 727-733 (2015).
38. Gu, J. et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. CRIT CARE 15, R153 (2011).
39. Paris, A. et al. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. ANESTH ANALG 102, 456-461 (2006).
40. Ibacache, M. et al. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochim Biophys Acta 1822, 537-545 (2012).
41. Xianbao, L., Hong, Z., Xu, Z., Chunfang, Z. & Dunjin, C. Dexmedetomidine reduced cytokine release during postpartum bleeding-induced multiple organ dysfunction syndrome in rats. Mediators Inflamm 2013, 627831 (2013).
42. Tufek, A. et al. The protective effect of dexmedetomidine on bupivacaine-induced sciatic nerve inflammation is mediated by mast cells. CLIN INVEST MED 36, E95-E102 (2013).
43. Wu, Y. et al. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-kappaB pathway. Mediators Inflamm 2013, 562154 (2013).
44. Lahdesmaki, J., Scheinin, M., Pertovaara, A. & Mansikka, H. The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception. EUR J PHARMACOL 468, 183-189 (2003).
45. Kable, J. W., Murrin, L. C. & Bylund, D. B. In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J PHARMACOL EXP THER 293, 1-7 (2000).
46. Ma, D. et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. EUR J PHARMACOL 502, 87-97 (2004).
47. Billings, F. T. et al. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol 295, F741-F748 (2008).
48. Hanci, V., Yurdakan, G., Yurtlu, S., Turan, I. O. & Sipahi, E. Y. Protective effect of dexmedetomidine in a rat model of alpha-naphthylthiourea-induced acute lung injury. J SURG RES 178, 424-430 (2012).
49. Chi, X. et al. Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling. J TRANSL MED 13, 190 (2015).
50. Wang, Y., Cai, J. & Yu, X. Effects of Dexmedetomidine Preconditioning on Gut Injury after Orthotopic Autologous Liver Transplantation in Rats. Journal of Sun Yat-sen university (medical sciences) 34, 845-850 (2013).
51. Sanders, R. D. et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. ANESTHESIOLOGY 110, 1077-1085 (2009).
52. Sahin, T. et al. The effects of dexmedetomidine on liver ischemia-reperfusion injury in rats. J SURG RES 183, 385-390 (2013).
53. Chi, X. et al. Knockdown of myeloid differentiation protein-2 reduces acute lung injury following orthotopic autologous liver transplantation in a rat model. PULM PHARMACOL THER 26, 380-387 (2013).
54. Yao, W. et al. Propofol activation of the Nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model. OXID MED CELL LONGEV 2014, 258567 (2014).
55. Luo, C. et al. Propofol attenuated acute kidney injury after orthotopic liver transplantation via inhibiting gap junction composed of connexin 32. ANESTHESIOLOGY 122, 72-86 (2015).
56. Sauvant, C. et al. Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia. CELL PHYSIOL BIOCHEM 24, 567-576 (2009).
57. Luo, C. et al. Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells. Life sciences 122, 72-77 (2015).
58. Hamar, P. et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 101, 14883-14888 (2004).